Bradykinin antagonists as new drugs for prostate cancer. Int Immunopharmacol 2: 1781-1786, 2002.Stewart JM;Chan DC; Simkeviciene V;.Bradykininantagonists as new drugs for prostate cancer.Int Im-munopharmacol.2002.1781-1786Stewart JM, Chan DC, Simkeviciene V, Bunn PA Jr, Helfrich B, York EJ...
Investigational New Drugs is a forum for rapid dissemination of information on new anticancer agents. The journal publishes original articles dealing with ...
Prostate cancerNew drugs in prostate cancerArmstrong, Andrew J.; Carducci, Michael A.Abstract Purpose of review: The survival of hormone-refractory metastatic prostate cancer patients has improved with the use of docetaxel-based chemotherapy. The survival benefits, however, are modest suggesting that ...
are now being used earlier, in settings including nonmetastatic castration-resistant prostate cancer and metastatic hormone-sensitive prostate cancer. This puts physicians in a position where there is uncertainty of how to treat when their patients relapse after treatment since these drugs are not curat...
"Improved imaging can provide physicians with the insights to determine the most appropriate treatment pathway and give patients in the US access to a specific and sensitive imaging tool for the detection of prostate cancer throughout the body," Christian Behrenbruch, MD, Telix CEO, said in a ...
Go to:Depression may double with new Prostate Cancer Drugs *** References: 1. Xtandi-official patient site 2. Depression and prostate cancer: implications for urologists and oncologists; Christopher F. Sharpley et al;Nature Reviews Urology volume 17, pages 571–585 (2020) . ...
Chemotherapy and New Drugs in Prostate Cancer 来自 Ingenta 喜欢 0 阅读量: 12 作者: Nicolas Mottet 摘要: is no evidence of superiority of one therapeutic modality over the others as no formal head-to- head comparison is available. Furthermore, the inclusion criteria are different across the...
Scientists at Bath, funded by Prostate Cancer UK with support from the Movember Foundation, have developed an innovative tool to test potential drugs forprostate cancer. The researchers hope this technique will help speed up the development of new treatments for the disease, the most common form o...
After a decade and a half of near stagnation, four new drugs could help make advanced prostate cancer a chronic illness instead of a terminal disease, a leading Colorado prostate cancer expert says.
Australian Prostate Cancer Research Center-Queensland Director Professor Nelson said the research team had been investigating twonovel drugsthat target fat hormones, onehormonewhich is pro-inflammatory, and another hormone that has an anti-inflammatory effect; each of which is involved in the progression...